{"first_name":"Thierry","last_name":"Pelet","permalink":"thierry-pelet","crunchbase_url":"http://www.crunchbase.com/person/thierry-pelet","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Tue Feb 14 12:00:56 UTC 2012","updated_at":"Tue Feb 14 12:01:50 UTC 2012","overview":"<p>Of scientific background, Thierry Pelet worked for many years in the virology field on topics including molecular determinant of viral replication, viral pathogenesis and budding process. He obtained its PhD in molecular virology in 1996 at the University of Geneva. He then performed his post-doctoral studies at the Clinical Research Institute in Montreal, Canada. Back to Switzerland, he worked as a senior scientist in several virology laboratories. His publications include more than a dozen of scientific papers in peer-reviewed virology journals. Thierry is a co-founder of Viroblock and was the CEO of the company until 2010.</p>","image":null,"degrees":[],"relationships":[{"is_past":false,"title":"CSO","firm":{"name":"Viroblock","permalink":"viroblock","type_of_entity":"company","image":{"available_sizes":[[[150,57],"assets/images/resized/0017/4197/174197v1-max-150x150.jpg"],[[246,95],"assets/images/resized/0017/4197/174197v1-max-250x250.jpg"],[[246,95],"assets/images/resized/0017/4197/174197v1-max-450x450.jpg"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}